STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumorsHeehyoung Lee, Hua Yu, Jiehui Deng et al.|Nature Medicine|2010Cited by 395
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responsesMarcin Kortylewski, Hua Yu, Andreas Herrmann et al.|Nature Biotechnology|2009Cited by 378
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoQifang Zhang, Marcin Kortylewski|Blood|2013Cited by 109
Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunityDayson Moreira, Marcin Kortylewski|Journal of Clinical Investigation|2020Cited by 82
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3Jeremy Hall, Marcin Kortylewski|Molecular Therapy — Nucleic Acids|2024Cited by 31